Recombinant Mouse sAPRIL/TNFSF13

Recombinant Biotinylated Human KIR2DL1 Protein,His-Avi Tag性能參數(shù)分子別名（Synonyms）CD158A;CD158Ankat1;cl-42表達(dá)區(qū)間及表達(dá)系統(tǒng)（Source）BiotinylatedHumanKIR2DL1ProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.ItcontainsHis22-Arg242.[Accession|P43626]分子量大小（MolecularWeight）TheproteinhasapredictedMWof27.1kDa.Duetoglycosylation,theproteinmigratesto48-60kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGEandHPLC.制劑（Formulation）Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重構(gòu)方法（Reconstitution）Centrifugethetubebeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.在體內(nèi)，活化的X因子（Factor Xa）切割凝血酶原，釋放出活性肽并將凝血酶切割成具有催化活性的α-凝血酶。Recombinant Mouse sAPRIL/TNFSF13

Recombinant Biotinylated Human HBV (HLA-A*02:01) Protein,His-Avi Tag性能參數(shù)表達(dá)區(qū)間及表達(dá)系統(tǒng)（Source）RecombinantBiotinylatedHumanHBV(HLA-A*02:01)ProteinisexpressedfromHEK293withHistagandAvitagattheC-terminalItcontainsGly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)andFLLTRILTIpeptide.[Accession|A0A140T913(HLA-A*02:01)&P61769(B2M)&FLLTRILTIpeptide]分子量大?。∕olecularWeight）TheproteinhasapredictedMWof50.5kDa.Duetoglycosylation,theproteinmigratesto52-62kDabasedonTris-BisPAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedby>95%asdeterminedbyHPLC制劑（Formulation）Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重構(gòu)方法（Reconstitution）Centrifugetubesbeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.Recombinant Human SEMA4B Protein,His TagUbcH5a/UBE2D1具有一個(gè)保守的E2催化結(jié)構(gòu)域，該結(jié)構(gòu)域含有一個(gè)活性位點(diǎn)半胱氨酸殘基。

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS?CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 .The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Before binding to the ACE-2 receptor, structural analysis of the S1 trimer shows that only one of the three RBD domains is in the "up" conformation. This is an unstable and transient state that passes between trimeric subunits but is nevertheless an exposed state to be targeted for neutralizing antibody therapy. Polyclonal antibodies to the RBD of the SARS-CoV-2 protein have been shown to inhibit interaction with the ACE-2 receptor, confirming RBD as an attractive target for vaccinations or antiviral therapy.  

CD19蛋白在B細(xì)胞和體液免疫反應(yīng)中起著作用。成熟B細(xì)胞對(duì)抗原刺激、胚芽中心發(fā)育和抗體親和性成熟的反應(yīng)能力是必需的。CD19已成為血液學(xué)和實(shí)體的有前途的靶點(diǎn)。產(chǎn)品性質(zhì)同義詞CD19;B4;CVID3;Leu-12;MGC12802工會(huì)編號(hào)P15391來(lái)源生化重組人CD19蛋白表達(dá)于HK293細(xì)胞,標(biāo)記于C-端。它含有金屬1-Lys291。分子量重組cd19由283個(gè)氨基酸組成,預(yù)測(cè)分子質(zhì)量為31.6kda。純潔90%由社會(huì)發(fā)展秘書(shū)處----政策和兩性平等局確定。內(nèi)用Lal法測(cè)定每一種蛋白質(zhì)。公式化用0.22腔形過(guò)濾液對(duì)PBS進(jìn)行凍干。凍干前添加5%-8%海藻糖、甘露醇和0.01%TWEen80作為保護(hù)劑。重建離心管打開(kāi)前。建議將其重組為100克/毫升以上的濃度。在蒸餾水中溶解凍干蛋白。OSM與白血病抑制因子（LIF）密切相關(guān)，實(shí)際上，除了其在人類(lèi)中的特定受體外，它實(shí)際上還使用了LIF受體。

Recombinant Biotinylated Human OX40/TNFRSF4/CD134 Protein (Primary Amine Labeling),hFc Tag性能參數(shù)分子別名（Synonyms）OX40Lreceptor;CD134;TNFRSF4;Ly-70表達(dá)區(qū)間及表達(dá)系統(tǒng)（Source）BiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling)isexpressedfromHEK293withhFctagattheC-Terminus.ItcontainsLeu29-Ala216.[Accession|P43489]分子量大?。∕olecularWeight）TheproteinhasapredictedMWof46.8kDa.Duetoglycosylation,theproteinmigratesto72-75kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGE制劑（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).儲(chǔ)存條件Theproductshouldbestoredat-85~-65℃for1yearfromdateofreceipt.R是通過(guò)CCR5受體發(fā)出信號(hào)的CC趨化因子。 LAG-1與MIP-1β（ACT II同種型）相同，但兩個(gè)氨基酸取代。Recombinant Human CD1A Protein,His Tag

UbcH7耗盡導(dǎo)致S期延長(zhǎng)和增殖速率降低，提示它可能在細(xì)胞周期中起作用。Recombinant Mouse sAPRIL/TNFSF13

Cas9核酸酶是一種引導(dǎo)RNA引導(dǎo)的核酸內(nèi)切酶，可以催化雙鏈DNA的裂解。這種靶向核酸酶是一種高精度的基因組編輯的有力工具。Cas9蛋白與CRISPR/Cas9系統(tǒng)的引導(dǎo)RNA（gRNA）成分形成一個(gè)非常穩(wěn)定的核糖白（RNP）復(fù)合物。Cas9RNP復(fù)合物可以在進(jìn)入細(xì)胞后，通過(guò)添加一個(gè)N端核定位信號(hào)（NLS），增加入核效率。YEASEN開(kāi)發(fā)的NLS-Cas9核酸酶在蛋白的N端包含一個(gè)核定位序列（NLS），以增加入核切割效率。產(chǎn)品特點(diǎn)如下：無(wú)DNA：沒(méi)有外部DNA添加。安全性好：野生型Cas9蛋白，無(wú)標(biāo)簽。可應(yīng)用于：通過(guò)體外DNA切割篩選高效和特異性靶向gRNA。產(chǎn)品信息貨號(hào)11366ES60/11366ES76規(guī)格100μg/500μg來(lái)源重組Cas9來(lái)源于大腸桿菌物種化膿性鏈球菌標(biāo)簽無(wú)分子量160KDa濃度10mg/mL（50μg）；10mg/mL（100μg）Recombinant Mouse sAPRIL/TNFSF13

浦斯瑞（上海）生物醫(yī)藥有限公司匯集了大量的優(yōu)秀人才，集企業(yè)奇思，創(chuàng)經(jīng)濟(jì)奇跡，一群有夢(mèng)想有朝氣的團(tuán)隊(duì)不斷在前進(jìn)的道路上開(kāi)創(chuàng)新天地，繪畫(huà)新藍(lán)圖，在江蘇省等地區(qū)的化工中始終保持良好的信譽(yù)，信奉著“爭(zhēng)取每一個(gè)客戶(hù)不容易，失去每一個(gè)用戶(hù)很簡(jiǎn)單”的理念，市場(chǎng)是企業(yè)的方向，質(zhì)量是企業(yè)的生命，在公司有效方針的領(lǐng)導(dǎo)下，全體上下，團(tuán)結(jié)一致，共同進(jìn)退，**協(xié)力把各方面工作做得更好，努力開(kāi)創(chuàng)工作的新局面，公司的新高度，未來(lái)浦斯瑞（上海）生物醫(yī)藥供應(yīng)和您一起奔向更美好的未來(lái)，即使現(xiàn)在有一點(diǎn)小小的成績(jī)，也不足以驕傲，過(guò)去的種種都已成為昨日我們只有總結(jié)經(jīng)驗(yàn)，才能繼續(xù)上路，讓我們一起點(diǎn)燃新的希望，放飛新的夢(mèng)想！